Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)- poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2665-2675

  Niu, Yunfei ^a   Dong, Wei ^a   Guo, Han ^b   Deng, Yuhu ^c   Guo, Lieping ^a   An, Xiaofei ^a   He, Dawei ^a   Wei, Jie ^c   Li, Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^c East China University of Science and Technology   (China)

Author keywords

Cell attachment; Cell proliferation; Cytocompatibility; Degradation; PCL PEG PCL

Indexed keywords

APATITE; MAGNESIUM SILICATE; MESOPOROUS MAGNESIUM SILICATE; MESOPOROUS MAGNESIUM SILICATE INCORPORATED POLY(EPSILON CAPROLACTONE)POLY(ETHYLENE GLYCOL)POLY(EPSILON CAPROLACTONE) BIOACTIVE COMPOSITE; NANOCOMPOSITE; PHOSPHATE BUFFERED SALINE; POLY(EPSILON CAPROLACTONE)POLY(ETHYLENE GLYCOL)POLY(EPSILON CAPROLACTONE); POLYMER; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; MAGNESIUM TRISILICATE; POLY(EPSILON-CAPROLACTONE)-B-POLY(ETHYLENEGLYCOL)-B-POLY(EPSILON-CAPROLACTONE); POLYESTER;

ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMICAL PARAMETERS; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DEGRADATION; HYDROPHILICITY; IN VITRO STUDY; OSTEOBLAST; STRUCTURE ANALYSIS; YOUNG MODULUS; BODY FLUID; BONE DEVELOPMENT; CELL LINE; CHEMISTRY; CYTOLOGY; DEVICE FAILURE ANALYSIS; EQUIPMENT DESIGN; HUMAN; NANOPORE; PHYSIOLOGY; POROSITY; TISSUE SCAFFOLD; ULTRASTRUCTURE;

BODY FLUIDS; CELL LINE; CELL PROLIFERATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MAGNESIUM SILICATES; NANOPORES; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS; POLYETHYLENE GLYCOLS; POROSITY; TISSUE SCAFFOLDS;

EID: 84901483154     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S59040     Document Type: Article

References (29)

1. He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater. 2014;26:391-411.
2. He QJ, Shi JL. Mesoporoussilicananoparticlebasednanodrug delivery systems: synthesis, controlleddrug release anddelivery, pharmacokinetics and biocompatibility. J Mater Chem. 2011;21:5845-5855.
3. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry. 2006;12: 5934-5943.
4. Vallet-Regí M, Izquierdo-Barba I, Colilla M. Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery. Philos Trans A Math Phys Eng Sci. 2012;370:1400-1421.
5. Zhu M, Zhang JH, Zhou YH, etal. Preparation and characterization of magnetic mesoporous bioactive glass/carbon composite scaffolds. Journal Chem. 2013;2013:893479.
6. Yan X, Yu C, Zhou X, Tang J, Zhao D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl. 2004;43:5980-5984.
7. Wu C, Zhou Y, Fan W, etal. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials. 2012;33:2076-2085.
8. Liu CB, Gong CY, Huang MJ, etal. Thermoreversible gel-sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions. J Biomed Mater Res B Appl Biomater. 2008;84:165-175.
9. Wang W, Deng L, Liu S, etal. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol) co-polymer. Acta Biomater. 2012;8:3963-3973.
10. Gong CY, Dong PW, Shi S, etal. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. J Pharm Sci. 2009;98:3707-3717.
11. Li X, Shi JL, Dong X, Zhang L, Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J Biomed Mater Res A. 2008;84:84-91.
12. He QJ, Huang ZL, Liu Y, Chen W, Xu T. Template-directed one-step synthesis of flowerlike porous carbonatedhydroxyapatitespheres. Mater Lett. 2007;61:141-143.
13. Fu SZ, Wang XH, Guo G, etal. Preparation and characterization of nano-hydroxyapatite/poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) composite fibers for tissue engineering. J Phys Chem. 2010;114:18372-18378.
14. Kokubo T, Matsushita T, Takadama H, Kizuki T. Development of bioactive materials basedonsurfacechemistry. J Eur Ceram Soc. 2009;29:1267-1274.
15. Yun HS, Kim SE, Hyun YT, Heo SJ, Shin JW. Three-dimensional mesoporous-giantporous inorganic/organic composite scaffolds for tissue engineering. Chem Mat. 2007;19:6363-6366.
16. Su J, Cao L, Yu B, etal. Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair. Int J Nanomedicine. 2012;7:2547-2555.
17. Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials. 2004;25:53-61.
18. Parent LR, Robinson DB, Woehl TJ, etal. Direct in situ observation of nanoparticle synthesis in a liquid crystal surfactant template. ACS Nano. 2012;6:3589-3596.
19. Holmes CA, Tabrizian M. Enhanced MC3T3 preosteoblast viability and adhesion on polyelectrolyte multilayer films composed of glycol-modified chitosan and hyaluronic acid. J Biomed Mater Res A. Epub November 29, 2011.
20. Huang W, Lv X, Liu C, etal. The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem. 2012;287:26245-26253.
21. Lu X, Leng Y. Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials. 2005;26:1097-1108.
22. Azami M, Moosavifar MJ, Baheiraei N, Moztarzadeh F, Ai J. Preparation of a biomimetic nanocomposite scaffold for bone tissue engineering via mineralization of gelatin hydrogel and study of mineral transformation in simulated body fluid. J Biomed Mater Res A. 2012;100:1347-1355.
23. Wu CT, Fan W, Chang J. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect onbonecancer cells. J Mater Chem B. 2013;1:2710-2718.
24. Wang J, Layrolle P, Stigter M, de Groot K. Biomimetic and electrolytic calcium phosphate coatings on titanium alloy: physicochemical characteristics and cell attachment. Biomaterials. 2004;25:583-592.
25. Oyane A, Wang X, Sogo Y, Ito A, Tsurushima H. Calcium phosphate composite layers for surface-mediated gene transfer. Acta Biomater. 2012;8:2034-2046.
26. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47-55.
27. Zinelis S, Thomas A, Syres K, Silikas N, Eliades G. Surface characterization of zirconia dental implants. Dent Mater. 2010;26: 295-305.
28. Prodanov L, Lamers E, Domanski M, Luttge R, Jansen JA, Walboomers XF. The effect of nanometric surface texture on bone contact to titanium implants in rabbit tibia. Biomaterials. 2013;34:2920-2927.
29. 2-CaO-P2O5-MgO-K2O-Na2O system) ions. Acta Biomater. 2009;5:3536-3547.